{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:52:04Z","timestamp":1792795924499,"version":"4.5.0"},"reference-count":58,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T00:00:00Z","timestamp":1653350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Monash University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Advances in scientific understanding have led to novel therapies and improved supportive care for many patients with haematological malignancies. However, these new drugs are often costly, only available at centralised health care facilities, require regular specialist reviews and lengthy treatment regimens. This leads to a significant financial burden. Understanding the impact of financial burden on haematological patients is important to appreciate the urgency of alleviating this systemic issue. Method: Eligible studies were identified by systematically searching Medline, PsycINFO, CINAHL and Embase. Self-reported data reported in both quantitative and qualitative studies that described the financial burden for patients with haematological malignancies were included. Quality appraisal of the included studies was undertaken using the Joanna Briggs Institute tools. A narrative synthesis was employed. For quantitative studies, outcomes were extracted, tabulated and categorised to find similarities and differences between the studies. For qualitative studies, quotations, codes and themes were extracted and then clustered. An inductive approach derived qualitative themes. Results: Twenty studies were identified for inclusion. Of the quantitative studies most (83%) employed un-validated researcher-generated measures to assess financial burden. Between 15\u201359% of patients experienced a financial burden. Out-of-pocket expenditure was frequent for clinical appointments, prescription and non-prescription medication, and travel. Financial burden was associated with a worsening quality of life and living in metropolitan areas, but there was no evidence for impact on survival. Patient-centred experiences from the qualitative inquiry complemented the quantitative findings and five themes were determined: familial or household impact; reliance on others; barriers to care due to cost; and barriers to accessing financial assistance and sources of out-of-pocket expenses. Conclusion: The impacts of financial burden are yet to be fully appreciated in haematological malignancies, exacerbated by the heterogeneous methods employed by researchers. Future work should focus on identifying the long-term ramifications of financial burden for patients and should trial interventions to reduce its prevalence and patient impacts.<\/jats:p>","DOI":"10.3390\/curroncol29060305","type":"journal-article","created":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T22:04:06Z","timestamp":1653429846000},"page":"3807-3824","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Patient Perceived Financial Burden in Haematological Malignancies: A Systematic Review"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-3075","authenticated-orcid":false,"given":"Catriona","family":"Parker","sequence":"first","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne 3004, Australia"},{"name":"Department of Haematology, Alfred Health, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Berkovic","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshini","family":"Ayton","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Zomer","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Liew","sequence":"additional","affiliation":[{"name":"School of Public Health and Preventive Medicine, Monash University, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Haematology, Alfred Health, Melbourne 3004, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,24]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study","volume":"5","author":"Chiattone","year":"2019","journal-title":"J. Glob. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","article-title":"Diagnosis and management of acute myeloid leukemia in adults: Recommendations from an international expert panel, on behalf of the European LeukemiaNet","volume":"115","author":"Dohner","year":"2010","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"djw205","DOI":"10.1093\/jnci\/djw205","article-title":"Financial Hardships Experienced by Cancer Survivors: A Systematic Review","volume":"109","author":"Altice","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_4","first-page":"80","article-title":"Financial Toxicity, Part I: A New Name for a Growing Problem","volume":"27","author":"Zafar","year":"2013","journal-title":"Oncology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40271-016-0204-x","article-title":"A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can\u2019t Pay the Co-Pay","volume":"10","author":"Gordon","year":"2017","journal-title":"Patient\u2014Patient-Cent. Outcomes Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.6004\/jnccn.2019.7305","article-title":"Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes","volume":"17","author":"Smith","year":"2019","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JOP.2014.001542","article-title":"Population-Based Assessment of Cancer Survivors\u2019 Financial Burden and Quality of Life: A Prospective Cohort Study","volume":"11","author":"Zafar","year":"2015","journal-title":"J. Oncol. Pr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1634\/theoncologist.2015-0026","article-title":"Financial Distress and Its Associations with Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer Patients","volume":"20","author":"Ferrer","year":"2015","journal-title":"Oncologist"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.2015.63.2232","article-title":"Association of Financial Strain with Symptom Burden and Quality of Life for Patients with Lung or Colorectal Cancer","volume":"34","author":"Lathan","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2013-0374","article-title":"Self-Reported Financial Burden and Satisfaction with Care Among Patients with Cancer","volume":"19","author":"Chino","year":"2014","journal-title":"Oncologist"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient\u2019s Experience","volume":"18","author":"Zafar","year":"2013","journal-title":"Oncologist"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1200\/JOP.2014.001406","article-title":"Patient-Oncologist Cost Communication, Financial Distress, and Medication Adherence","volume":"10","author":"Bestvina","year":"2014","journal-title":"J. Oncol. Pr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1002\/cncr.28262","article-title":"Are survivors who report cancer-related financial problems more likely to forgo or delay medical care?","volume":"119","author":"Kent","year":"2013","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.2013.53.0956","article-title":"Long-term financial burden of breast cancer: Experiences of a diverse cohort of survivors identified through population-based registries","volume":"32","author":"Jagsi","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","article-title":"Financial Insolvency as a Risk Factor for Early Mortality Among Patients with Cancer","volume":"34","author":"Ramsey","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00520-014-2474-y","article-title":"The perceived cancer-related financial hardship among patients and their families: A systematic review","volume":"23","author":"Azzani","year":"2015","journal-title":"Support. Care Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1007\/s00520-020-05620-9","article-title":"Financial toxicity associated with a cancer diagnosis in publicly funded healthcare countries: A systematic review","volume":"28","author":"Longo","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_18","unstructured":"National Institute for Health Research (2022, May 16). PROSPERO: International Prospective Register of Systematic Reviews [Internet]. PROSPERO., Available online: https:\/\/www.crd.york.ac.uk\/prospero\/#aboutpage."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"ref_20","unstructured":"Joanna Briggs Institute (2021, June 07). Critical-Appraisal-Tools\u2014Critical Appraisal Tools | Joanna Briggs Institute [Internet]. Available online: https:\/\/jbi.global\/critical-appraisal-tools."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Aromataris, E., and Munn, Z. (2020). Chapter 8: Mixed Methods Systematic Reviews. JBI Manual for Evidence Synthesis, JBI. Available online: https:\/\/wiki.jbi.global\/display\/MANUAL\/Chapter+8%3A+Mixed+methods+systematic+reviews.","DOI":"10.46658\/JBIRM-17-01"},{"key":"ref_22","unstructured":"Popay, J., Roberts, H., Sowden, A., Petticrew, M., Arai, L., Rodgers, M., Britten, N., Roen, K., and Duffy, S. (2006). Guidance on the Conduct of Narrative Synthesis in Systematic Reviews: A Product from the ESRC Methods Programme, Lamcaster University."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.bbmt.2016.05.008","article-title":"Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation","volume":"22","author":"Abel","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s11136-019-02150-8","article-title":"Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation","volume":"28","author":"Albelda","year":"2019","journal-title":"Qual. Life Res."},{"key":"ref_25","first-page":"258","article-title":"Perceived economic hardship and distress in acute myelogenous leukemia","volume":"8","author":"Dudkaj","year":"2017","journal-title":"J. Oncol. Navig. Surviv."},{"key":"ref_26","first-page":"168","article-title":"Medication Adherence among Patients with Chronic Myeloid Leukemia: The Impact of Financial Burden and Psychosocial Distress","volume":"8","author":"Buzaglo","year":"2017","journal-title":"J. Oncol. Navig. Surviv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JOP.2013.001322","article-title":"Impact of Financial Burden of Cancer on Survivors\u2019 Quality of Life","volume":"10","author":"Fenn","year":"2014","journal-title":"J. Oncol. Pr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/NCC.0b013e3182693522","article-title":"Personal Financial Effects of Multiple Myeloma and Its Treatment","volume":"36","author":"Goodwin","year":"2013","journal-title":"Cancer Nurs."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/pon.3091","article-title":"Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation: Economic survivorship stress and HRQOL","volume":"22","author":"Hamilton","year":"2013","journal-title":"Psycho-Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1016\/S2352-3026(15)00151-9","article-title":"Financial toxicity in insured patients with multiple myeloma: A cross-sectional pilot study","volume":"2","author":"Huntington","year":"2015","journal-title":"Lancet Haematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1158\/1055-9965.EPI-17-1040","article-title":"Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival","volume":"27","author":"Khera","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00520-017-3918-y","article-title":"As if the disease was not enough: Coping with the financial consequences of cancer","volume":"26","author":"Head","year":"2018","journal-title":"Support. Care Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/j.clml.2021.02.013","article-title":"Risk Factors for Cost-Related Delays to Medical Care Among Lymphoma Patients: A 22-Year Analysis of a Nationally Representative Sample","volume":"21","author":"Jella","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.clml.2018.01.006","article-title":"Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients with Multiple Myeloma","volume":"18","author":"Gupta","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00981389.2015.1130008","article-title":"Financial distress during relocation for treatment of a hematological malignancy: Findings for social work","volume":"55","author":"McGrath","year":"2016","journal-title":"Soc. Work Health Care"},{"key":"ref_36","first-page":"2893","article-title":"\u2018The bills that were coming in\u2026\u2019: Out of pocket costs during relocation for specialist treatment for haematological malignancies","volume":"24","author":"McGrath","year":"2016","journal-title":"Support. Care Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1054137315587633","article-title":"The Use of Credit Cards in Response to the Crisis of Serious Illness","volume":"24","author":"McGrath","year":"2016","journal-title":"Illn. Crisis Loss"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1080\/00981389.2015.1061088","article-title":"Informal financial assistance for patients with a hematological malignancy: Implications for oncology social work practice","volume":"54","author":"McGrath","year":"2015","journal-title":"Soc. Work Health Care"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"s43","DOI":"10.1111\/jrh.12020","article-title":"Access to Care and Impacts of Cancer on Daily Life: Do They Differ for Metropolitan Versus Regional Hematological Cancer Survivors?","volume":"29","author":"Paul","year":"2013","journal-title":"J. Rural. Health"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Parsons, J.A., Greenspan, N.R., Baker, N.A., McKillop, C., Hicks, L.K., and Chan, O. (2019). Treatment preferences of patients with relapsed and refractory multiple myeloma: A qualitative study. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5467-x"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/pon.4023","article-title":"A qualitative exploration of the unmet psychosocial rehabilitation needs of cancer survivors in China: Psychosocial rehabilitation needs","volume":"25","author":"Wang","year":"2016","journal-title":"Psycho-Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2147\/PPA.S132894","article-title":"Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: A qualitative study","volume":"11","author":"Tan","year":"2017","journal-title":"Patient Prefer. Adherence"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/002214650504600305","article-title":"Stress, Life Events, and Socioeconomic Disparities in Health: Results from the Americans\u2019 Changing Lives Study","volume":"46","author":"Lantz","year":"2005","journal-title":"J. Health Soc. Behav."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"djv410","DOI":"10.1093\/jnci\/djv410","article-title":"Minimizing the \u201cFinancial Toxicity\u201d Associated with Cancer Care: Advancing the Research Agenda","volume":"108","author":"Yabroff","year":"2016","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13012-014-0118-8","article-title":"Instrumentation issues in implementation science","volume":"9","author":"Martinez","year":"2014","journal-title":"Implement. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3322\/caac.21443","article-title":"The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment","volume":"68","author":"Carrera","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/annonc\/mdz140","article-title":"Methods for measuring financial toxicity after cancer diagnosis and treatment: A systematic review and its implications","volume":"30","author":"Witte","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1007\/s11606-019-05002-w","article-title":"Prevalence and Correlates of Medical Financial Hardship in the USA","volume":"34","author":"Yabroff","year":"2019","journal-title":"J. Gen. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/cncr.31913","article-title":"Medical financial hardship among cancer survivors in the United States","volume":"125","author":"Zheng","year":"2019","journal-title":"Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ygyno.2011.11.038","article-title":"Does Economic Burden Influence Quality of Life in Breast Cancer Survivors?","volume":"124","author":"Meneses","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/pon.3055","article-title":"Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer","volume":"22","author":"Sharp","year":"2013","journal-title":"Psycho-Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1001\/jamaoncol.2020.4660","article-title":"Association of Generic Imatinib Availability and Pricing with Trends in Tyrosine Kinase Inhibitor Use in Patients with Chronic Myelogenous Leukemia","volume":"6","author":"Lyman","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.bbmt.2017.07.024","article-title":"Ascertainment of Unmet Needs and Participation in Health Maintenance and Screening of Adult Hematopoietic Cell Transplantation Survivors Followed in a Formal Survivorship Program","volume":"23","author":"Hahn","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1002\/cncr.30940","article-title":"Setting the Stage for Universal Financial Distress Screening in Routine Cancer Care","volume":"123","author":"Khera","year":"2017","journal-title":"Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Moffatt, S., Noble, E., and Exley, C. (2010). \u2018Done more for me in a fortnight than anybody done in all me life.\u2019 How welfare rights advice can help people with cancer. BMC Health Serv. Res., 10.","DOI":"10.1186\/1472-6963-10-259"},{"key":"ref_56","first-page":"46","article-title":"Changes in Health, Negative Financial Events, and Financial Distress\/Financial Well-Being for Debt Management Program Clients","volume":"17","author":"Prawitz","year":"2006","journal-title":"J. Financ. Couns. Plan."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","article-title":"Life Expectancy of Patients with Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population","volume":"34","author":"Bower","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e2116357","DOI":"10.1001\/jamanetworkopen.2021.16357","article-title":"Phase-Specific and Lifetime Costs of Multiple Myeloma among Older Adults in the US","volume":"4","author":"Bhattacharya","year":"2021","journal-title":"JAMA Netw. Open"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/6\/305\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:17:49Z","timestamp":1760138269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/29\/6\/305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,24]]},"references-count":58,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["curroncol29060305"],"URL":"https:\/\/doi.org\/10.3390\/curroncol29060305","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,24]]}}}